Grifols Therapeutics LLC clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   SPARTA · Alpha1-Proteinase Inhibitor (Human), Modified Process…SPARTA · Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) · Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

   Trial completed

   Also in this update: Study completion date changed from estimate of Jan 2027 to Aug 5, 2026

   Grifols Therapeutics LLC·Phase 3· NCT01983241· Registry history of NCT01983241 on ClinicalTrials.gov (opens the registry)

   Updated Oct 1, 2026

2. Minor

   XPERT · XEMBIFY Versus Gamunex-C · Chronic Inflammatory…XPERT · XEMBIFY Versus Gamunex-C · Chronic Inflammatory Demyelinating Polyradiculoneuropathy

   Trial sites expanded: 10 → 15 locations

   Grifols Therapeutics LLC·Phase 3· NCT07540221· Registry history of NCT07540221 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.